Left ventricular remodeling and ventricular arrhythmias after myocardial infarction

Circulation

Volumn 107, Issue 20, 2003, Pages 2577-2582

  St John Sutton, Martin ^c   Lee, Douglas ^b   Rouleau, Jean Lucien ^b   Goldman, Steven ^d   Plappert, Ted ^c   Braunwald, Eugene ^a   Pfeffer, Marc A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

Arrhythmia; Echocardiography; Myocardial infarction; Remodeling

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ELECTROCARDIOGRAPHY MONITORING; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE SIZE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE REMODELING; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; TRANSTHORACIC ECHOCARDIOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0038187584     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.cir.0000070420.51787.a8     Document Type: Article

References (33)

1. Kostuk WJ, Kazamias TM, Gander MP, et al. Left ventricular size after acute myocardial infarction: serial changes and their prognostic significance. Circulation. 1973;47:1174-1179.
2. Erlebacher JA, Weiss JL, Weisfeldt ML, et al. Early dilation of the infarcted segment in acute transmural myocardial infarction: role of infarct expansion in acute left ventricular enlargement. J Am Coll Cardiol. 1984;4:201-208.
3. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation. 1990;81:1161-1172.
4. Gaudron P, Eilles C, Kugler I, et al. Progressive left ventricular dysfunction and remodeling after myocardial infarction: potential mechanisms and early predictors. Circulation. 1993;87:755-763.
5. Rohde LE, Aikawa M, Cheng GC, et al. Echocardiography-derived endsystolic regional wall stress and matrix remodeling after experimental myocardial infarction. J Am Coll Cardiol. 1999;33:835-842.
6. White HD, Norris RM, Brown MA, et al. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987;76:44-51.
7. Gettes LS, Cascio WE, Sanders WE. Mechanisms of sudden cardiac death. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. Philadelphia, Pa: WB Saunders; 1995:527-538.
8. Moss AJ, Zareiba W, Hall WJ, et al, for the Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883.
9. Bigger JT, Fleiss JL, Kleiger R, et al, and the Multicenter Post-Infarction Research Group. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation. 1984;69:250-258.
10. Dillon SM, Allessie MA, Ursell PC, et al. Influences of anisotropic tissue structure on reentrant circuits in the epicardial border zone of subacute canine infarcts. Circ Res. 1988;63:182-206.
11. Dambrink JH, Beukema WP, Van Gilst WH, et al. Left ventricular dilatation and high-grade ventricular arrhythmias in the first year after myocardial infarction: CATS Investigators Captopril and Thrombolysis Study. J Card Fail. 1994;1:3-11.
12. Pogwizd SM, Hoyt RH, Saffitz JE, et al. Reentrant and focal mechanisms underlying ventricular tachycardia in the human heart. Circulation. 1992;86:1872-1887.
13. Richards DA, Blake GJ, Spear JF, et al. Electrophysiologic substrate for ventricular tachycardia: correlation of properties in vivo and in vitro. Circulation. 1984;69:369-381.
14. Cardinal R, Vermeulen M, Shenassa M, et al. Anisotropic conduction and functional dissociation of ischemic tissue during reentrant ventricular tachycardia in canine myocardial infarction. Circulation. 1988;77:1162-1176.
15. Rouleau JL, de Champlain J, Klein M, et al. Activation of neurohumoral systems in post-infarction left ventricular dysfunction. J Am Coll Cardiol. 1993;22:390-398.
16. Corr PB, Yamada KA, Witkowski FX. Mechanisms controlling cardiac autonomic function and their relationship to arrhythmogenesis. In: Fozzard HA, Haber E, Jennings RB, et al, eds. The Heart and Cardiovascular System: Scientific Foundations. New York, NY: Raven Press; 1986.
17. Domanski MJ, Exner DV, Borkowf CB, et al. Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction: a meta-analysis of randomized clinical trials. J Am Coll Cardiol. 1999;33:598-604.
18. Tuininga YS, Wiesfeld ACP, van Veldhuisen DJ, et al. Electrophysiological changes of angiotensin-converting enzyme inhibition after myocardial infarction. J Card Fail. 2000;6:77-79.
19. St John Sutton M, Pfeffer MA, Moye L, et al, for the SAVE Investigators. Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) Trial. Circulation. 1997;96:3294-3299.
20. Pfeffer MA, Braunwald E, Moyé LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial. N Engl J Med. 1992;327:669-677.
21. St John Sutton M, Pfeffer MA, Plappert T, et al, for the SAVE Investigators. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after myocardial infarction: the protective effects of captopril. Circulation. 1994;89:68-75.
22. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: Wiley; 1989:140-145.
23. Sadoshima J, Jahn L, Takahashi T, et al. Molecular characterization of the stretch-induced adaptation of cultured cardiac cells: an in vitro model of load-induced cardiac hypertrophy. J Biol Chem. 1992;267:10551-10560.
24. Tyagi SC, Campbell SE, Reddy HK, et al. Matrix metalloproteinase activity expression in infarcted, non-infarcted and dilated cardiomyopathic human hearts. Mol Cell Biochem. 1996;155:13-21.
25. Weber KT. Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation. Circulation. 1997;96:4065-4082.
26. Nguyen T, Salibi EE, Rouleau JL. Postinfarction survival and inducibility of ventricular arrhythmias in the spontaneously hypertensive rat: effects of ramipril and hydralazine. Circulation. 1998;98:2074-2080.
27. Levy D, Anderson KM, Savage DD, et al. Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol. 1987;60:560-565.
28. Klein R. Ventricular arrhythmias in aortic valve disease: analysis of 102 patients. Am J Cardiol. 1984;53:1079-1083.
29. Maron BJ, Fananapazir L. Sudden cardiac death in hypertrophic cardiomyopathy. Circulation. 1992;85(suppl I):I-57-I-63.
30. Aronson RS. Mechanisms of arrhythmias in ventricular hypertrophy. J Cardiovasc Electrophysiol. 1991;21:729-739.
31. Kleinman RB, Houser SR. Calcium currents in normal and hypertrophied isolated feline ventricular myocytes. Am J Physiol. 1988;255:H1434-H1442.
32. Kleinman RB, Houser SR. Outward currents in normal and hypertrophied feline ventricular myocytes. Am J Physiol. 1989;256:H1450-H1461.
33. SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992;327:685-691.